Master Class on Overseas Listings

Master Class on Overseas Listings

The Masterclass on Overseas Listing panel discussion concluded on November 12, 2022, at Yas Island, Abu Dhabi.

The discussion gave the attendees of NATCON CREDAI National an overview of the current international market scenario with respect to the overseas listing. We would like to thank our panelists, Mr. Alex Walker, Mr. Kapil Singh, Mr. Gaurav Verma, Mr. Jesus Emilio Hoyos Quintero along with the moderator Mr. Chittransh Verma, who were able to bring the answers to the attendees through an insightful discussion on the topic.

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission